Capital Advisors Inc. OK Purchases 8,229 Shares of Stryker Corporation $SYK

Capital Advisors Inc. OK boosted its holdings in Stryker Corporation (NYSE:SYK) by 5.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 172,517 shares of the medical technology company’s stock after buying an additional 8,229 shares during the quarter. Capital Advisors Inc. OK’s holdings in Stryker were worth $60,635,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Clayton Financial Group LLC acquired a new position in Stryker in the 3rd quarter valued at approximately $26,000. United Financial Planning Group LLC bought a new position in shares of Stryker during the third quarter valued at $27,000. Elevation Point Wealth Partners LLC acquired a new position in shares of Stryker during the second quarter worth $28,000. Kilter Group LLC bought a new stake in shares of Stryker in the second quarter worth $29,000. Finally, Howard Hughes Medical Institute acquired a new stake in Stryker in the second quarter valued at $29,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. BTIG Research raised their target price on Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. TD Cowen cut Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target for the company. in a research note on Monday, January 26th. Evercore set a $390.00 price objective on Stryker in a research report on Monday, January 5th. Needham & Company LLC lifted their price objective on Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Finally, Citigroup reissued a “market outperform” rating on shares of Stryker in a research report on Friday, January 30th. Fourteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $427.50.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 5.20% of the company’s stock.

Stryker Stock Performance

Shares of SYK opened at $328.34 on Wednesday. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The firm’s fifty day simple moving average is $358.77 and its two-hundred day simple moving average is $362.73. Stryker Corporation has a 12 month low of $319.32 and a 12 month high of $404.87. The stock has a market capitalization of $125.75 billion, a P/E ratio of 39.09, a price-to-earnings-growth ratio of 1.91 and a beta of 0.85.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping the consensus estimate of $4.40 by $0.07. The firm had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period last year, the company posted $4.01 EPS. As a group, analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be paid a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s payout ratio is 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.